VIDEO: Dupixent in development for multiple inflammatory diseases

BOSTON — In this video, Sanofi Head of Global Development, Immunology and Inflammation Naimish Patel, MD, discusses research regarding dupilumab (Dupixent, Sanofi/Regeneron) presented at the American Academy of Dermatology Annual Meeting.